#pharma-competition

[ follow ]
#wegovy #oral-glp-1 #amazon-pharmacy #drug-pricing #oral-semaglutide #fda-approval #obesity-treatment
Medicine
fromFast Company
1 day ago

Wegovy just became available in an unexpected place

An oral version of Novo Nordisk's Wegovy will be sold through Amazon Pharmacy, increasing access for consumers who pay out of pocket.
fromFast Company
2 weeks ago

FDA approves Novo Nordisk weight-loss pill. Here's what to know

The U.S. Food and Drug Administration approved Novo Nordisk's weight-loss pill on Monday, giving the Danish drugmaker a leg up in the race to market a potent oral medication for shedding pounds as it looks to regain lost ground from rival Eli Lilly. The pill is 25 milligrams of semaglutide, the same active ingredient in injectable Wegovy and Ozempic, and will be sold under the brand name Wegovy. Novo already sells an oral semaglutide for type 2 diabetes, Rybelsus.
Medicine
Healthcare
fromFortune
2 months ago

Novo Nordisk wants to keep its crown leading the weight loss drugs pack-despite outlook downgrades and lawsuits, its CFO has a plan | Fortune

Novo Nordisk faces declining sales and stock after GLP-1 competition; success depends on launching new products like Wegovy pill, CagriSema, and amycretin.
Medicine
fromFast Company
3 months ago

Pfizer bets $7.3 billion on obesity drugs with Metsera buy

Pfizer is acquiring Metsera and its four obesity and cardiometabolic drug candidates for up to $7.3 billion to enter the weight-loss market.
[ Load more ]